RE: RE: RE: RE: RE: A Little More Explanation @KayakerBC, I acknowledge that RVX made that previous statement. But RVX has historically been very active at the annual ACC conferences and publishing in JACC. In terms of major cardiovascular disease conferences upcoming, there is ACC in March, ATVB in May and then AHA in November. Seems to me the ACC conference may be their last chance to excite people about SUSTAIN, since dosing for ASSURE will be done late March/early April and topline data for ASSURE will be announced sometime in the May/June timeframe. SUSTAIN topline data was announced almost 6 months ago. I don't see the logic in waiting until topline ASSURE data is available to present/publish on SUSTAIN. That would be a lost opportunity, IMO.